U.S. researchers found there were no big differences in cost, opioid use or complication rates among those using cannabis after hip arthroscopy.
To determine differences, if any, post-surgery among cannabis users and non-users, researchers collected data from a large commercial insurance database from 2010 to 2019. Self-reported weed users were matched by numerous factors — including age, procedure, gender, obesity and tobacco use — with non-users.
Following the procedures, investigators measured opioid use during the person’s care period and the 30-day cost, comparing cannabis users and non-users.
In all, 171 patients without cannabis use and 174 with cannabis use had full financial and opioid use data for analysis, researchers write.
The data shows “prescription opioid use was not significantly different over the episode of care in patients with reported cannabis use than those without reported cannabis use,” the investigators note.
There was also
Read full article on The Growth Op
